Characteristic
|
aWritten information
|
Muscle strengthening/ aerobic fitness exercise
|
bDieting to lose weight
|
Paracetamol
|
Topical NSAIDs
|
---|
n (%)
|
AOR (95% CI)
|
n (%)
|
AOR (95% CI)
|
n (%)
|
AOR (95% CI)
|
n (%)
|
AOR (95% CI)
|
n (%)
|
AOR (95% CI)
|
---|
Total
|
934
| |
618
| |
261
| |
1270
| |
1055
| |
Gender
|
Male
|
353 (20.1)
|
1
|
244 (13.9)
|
1
|
92 (7.1)
|
1
|
511 (29.1)
|
1
|
424 (24.1)
|
1
|
Female
|
581 (25.3)
|
1.28×× (1.09, 1.50)
|
374 (16.3)
|
1.12 (0.93, 1.35)
|
169 (11.5)
|
1.54×× (1.16, 2.04)
|
759 (33.0)
|
1.09 (0.94, 1.27)
|
631 (27.4)
|
1.13 (0.97, 1.32)
|
Age group (years)
|
45–54
|
190 (24.7)
|
1
|
133 (17.3)
|
1
|
37 (7.1)
|
1
|
149 (19.4)
|
1
|
150 (19.5)
|
1
|
55–64
|
298 (26.2)
|
1.02 (0.80, 1.29)
|
192 (16.9)
|
0.78 (0.60, 1.03)
|
90 (10.9)
|
1.52 (0.97, 2.36)
|
283 (25.0)
|
1.12 (0.87, 1.45)
|
243 (21.4)
|
0.96 (0.74, 1.24)
|
65–74
|
267 (21.8)
|
0.76 (0.56, 1.03)
|
183 (14.9)
|
0.55×× (0.38, 0.78)
|
99 (11.4)
|
1.64 (0.94, 2.86)
|
395 (32.2)
|
1.29 (0.94, 1.76)
|
341 (27.8)
|
1.20 (0.88, 1.64)
|
≥ 75
|
179 (19.3)
|
0.56×× (0.40, 0.79)
|
110 (11.9)
|
0.37××× (0.25, 0.55)
|
35 (6.4)
|
0.74 (0.39, 1.40)
|
443 (47.7)
|
1.91××× (1.38, 2.65)
|
321 (34.6)
|
1.32 (0.94, 1.84)
|
Employment status
|
Employed
|
277 (25.1)
|
1
|
171 (15.5)
|
1
|
56 (7.1)
|
1
|
203 (18.4)
|
1
|
197 (17.8)
|
1
|
Unemployed
|
143 (24.0)
|
0.74× (0.58, 0.98)
|
102 (17.1)
|
1.03 (0.77, 1.38)
|
49 (12.8)
|
1.06 (0.67, 1.66)
|
195 (32.7)
|
1.16 (0.90, 1.51)
|
157 (26.3)
|
1.17 (0.90, 1.52)
|
Retired
|
494 (21.9)
|
0.91 (0.71, 1.18)
|
327 (14.5)
|
1.17 (0.87, 1.58)
|
149 (9.7)
|
0.92 (0.58, 1.45)
|
841 (37.3)
|
1.15 (0.89, 1.50)
|
667 (29.6)
|
1.12 (0.86, 1.46)
|
No. of pain sites
|
Single site
|
116 (14.9)
|
1
|
106 (13.6)
|
1
|
31 (6.4)
|
1
|
180 (23.2)
|
1
|
151 (19.4)
|
1
|
Multi-site
|
818 (24.9)
|
1.59××× (1.26, 2.00)
|
512 (15.6)
|
0.98 (0.77, 1.26)
|
230 (10.1)
|
1.08 (0.70, 1.68)
|
1090 (33.2)
|
1.10 (0.88, 1.35)
|
904 (27.5)
|
1.15 (0.93, 1.43)
|
Morbidity burden (BNF drug count)
|
< 10 counts
|
501 (22.5)
|
1
|
294 (13.2)
|
1
|
87 (5.9)
|
1
|
451 (20.3)
|
1
|
419 (18.9)
|
1
|
≥ 10 counts
|
433 (23.6)
|
0.91 (0.75, 1.08)
|
324 (17.6)
|
1.44×× (1.16, 1.77)
|
174 (13.5)
|
1.87××× (1.37, 2.57)
|
819 (44.6)
|
1.88×××(1.60, 2.23)
|
636 (34.6)
|
1.61××× (1.35, 1.91)
|
BMI (Kg/m2)
|
Not overweight (< 25.0)
|
253 (21.8)
|
1
|
170 (14.6)
|
1
|
n/a
|
n/a
|
343 (29.5)
|
1
|
287 (24.7)
|
1
|
Overweight (25.0–29.9)
|
355 (22.4)
|
1.01 (0.83, 1.23)
|
246 (15.5)
|
1.02 (0.82, 1.27)
|
84 (5.3)
|
1
|
482 (30.4)
|
1.05 (0.87, 1.27)
|
420 (26.5)
|
1.12 (0.93, 1.35)
|
Obese (≥30.0)
|
295 (24.9)
|
0.96 (0.78, 1.18)
|
180 (15.2)
|
0.80 (0.63, 1.02)
|
177 (15.0)
|
2.48××× (1.85, 3.32)
|
388 (32.8)
|
0.95 (0.78, 1.16)
|
311 (26.3)
|
0.91 (0.74, 1.12)
|
SF12 – Physical health (Quartile)
|
Worst to 27.58
|
273 (27.7)
|
2.13××× (1.63, 2.77)
|
168 (17.0)
|
1.64×× (1.20, 2.24)
|
102 (14.2)
|
1.44 (0.89, 2.32)
|
467 (47.4)
|
2.64××× (2.04, 3.41)
|
344 (34.9)
|
1.67 × × × (1.28, 2.16)
|
27.59–38.36
|
249 (25.4)
|
1.76××× (1.38, 2.25)
|
167 (17.0)
|
1.67 ×××(1.26, 2.23)
|
75 (11.0)
|
1.29 (0.81, 2.05)
|
361 (36.8)
|
2.24××× (1.75, 2.87)
|
290 (29.6)
|
1.60 × × × (1.25, 2.04)
|
38.37–48.26
|
231 (23.1)
|
1.53××× (1.21, 1.93)
|
155 (15.5)
|
1.47×× (1.12, 1.93)
|
42 (6.2)
|
0.86 (0.53, 1.40)
|
261 (26.1)
|
1.70××× (1.33, 2.16)
|
225 (22.5)
|
1.26 (0.99, 1.61)
|
48.27–71.88
|
166 (16.9)
|
1
|
115 (11.7)
|
1
|
34 (5.5)
|
1
|
139 (14.1)
|
1
|
156 (15.8)
|
1
|
SF12 – Mental health (Quartile)
|
Worst to 39.93
|
275 (28.5)
|
1.42×× (1.12, 1.78)
|
176 (18.2)
|
1.11 (0.85, 1.44)
|
100 (14.0)
|
1.90×× (1.26, 2.84)
|
404 (41.9)
|
1.59××× (1.28, 1.97)
|
314 (32.5)
|
1.51××× (1.21, 1.89)
|
39.94–49.55
|
231 (23.5)
|
1.18 (0.95, 1.48)
|
140 (14.3)
|
0.97 (0.75, 1.26)
|
68 (10.6)
|
1.64×(1.08, 2.48)
|
337 (34.3)
|
1.34×× (1.08, 1.65)
|
290 (29.5)
|
1.48××× (1.18, 1.84)
|
49.56–57.11
|
207 (21.4)
|
1.14 (0.91, 1.43)
|
144 (14.9)
|
1.04 (0.80, 1.35)
|
43 (6.9)
|
1.10 (0.70, 1.74)
|
233 (24.1)
|
1.04 (0.84, 1.30)
|
203 (21.0)
|
1.09 (0.87, 1.37)
|
57.12 to 74.46
|
206 (19.8)
|
1
|
145 (14.0)
|
1
|
42 (5.8)
|
1
|
254 (24.5)
|
1
|
208 (20.0)
|
1
|
OA diagnosis
|
Yes
|
146 (29.1)
|
1.57××× (1.26, 1.96)
|
88 (17.5)
|
1.31× (1.00, 1.70)
|
31 (8.9)
|
0.79 (0.52, 1.21)
|
203 (40.4)
|
1.30× (1.05, 1.62)
|
166 (33.1)
|
1.30× (1.04, 1.62)
|
No
|
788 (22.2)
|
1
|
530 (14.9)
|
1
|
230 (9.5)
|
1
|
1067 (30.0)
|
1
|
889 (25.0)
|
1
|
- n is the number of participants who used core treatments out of 4059 eligible respondents. Number in the subcategories do not always sum to the total number of who used treatment due to missing data. % figures represent valid percent (i.e. excluding missing data)
- AOR adjusted odds ratio
- aWritten information is a composite variable derived from the addition of responses of participants who used information about treatments, information about self-management and information about OA when they consulted with joint pain; bRestricted to obese/overweight participants. n = 3742 in final multivariable analysis
- ×p < 0.05, ××p < 0.01, ×××p < 0.001